Inactive Instrument

Press Releases Receptos Inc

Equities

US7562071065

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2015	Bank of America : Wall Street edges lower as energy weighs	RE
2015	Celgene : Wall Street lauds Celgene's $7.2 billion Receptos buy	RE

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Receptos : Results of the Phase 2 TOUCHSTONE Trial - Report on Receptos, Inc.	22/15/22	PR
Receptos : Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases	17/15/17	PU
Receptos : Ryan & Maniskas, LLP : Investigation of Receptos, Inc.	17/15/17	PR
Receptos : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Receptos, Inc. Stockholders	16/15/16	BU
Receptos : Stockholders Encouraged to Contact Securities Law Firm about Takeover	15/15/15	PR
Receptos to Present at Jefferies 2015 Global Healthcare Conference	28/15/28	GL
Receptos Announces Oral Plenary Presentation of TOUCHSTONE Phase 2 Induction Data at Digestive Disease Week 2015	15/15/15	GL
Receptos to Present at UBS Global Healthcare Conference	14/15/14	GL
Receptos to Present at Bank of America Merrill Lynch 2015 Healthcare Conference	07/15/07	GL
Receptos to Hold First Quarter 2015 Results Conference Call	29/15/29	GL
Receptos : Active Equities to Watch in the Health Care Sector -- Cytori Therapeutics, Endo Intl., BioMarin Pharma, Novogen, and Receptos	23/15/23	PR
Receptos Reports Positive Results for the Maintenance Period of the Phase 2 TOUCHSTONE Trial of Ozanimod in Ulcerative Colitis	16/15/16	GL
Receptos Completes Enrollment of RADIANCE Phase 3 Trial of Ozanimod in Relapsing Multiple Sclerosis	01/15/01	GL
Receptos to Present at Barclays Global Healthcare Conference	09/15/09	GL
Receptos Provides Development Updates and Reports Fourth Quarter and Year End 2014 Financial Results	04/15/04	GL
Receptos to Hold Fourth Quarter and Year End 2014 Financial Results Conference Call	26/15/26	GL
Receptos Announces Oral Podium Presentation at Annual Meeting of European Crohn's and Colitis Organization (ECCO)	18/15/18	GL
Receptos to Present at Leerink Global Healthcare Conference	09/15/09	GL
Receptos Initiates SUNBEAM Phase 3 Trial of RPC1063 in Relapsing Multiple Sclerosis	22/14/22	GL
Receptos Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Completion of Underwritten Public Offering of Common Stock	24/14/24	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Receptos Inc

Equities

US7562071065

Press Releases

Filters